Everyone with Alzheimer’s disease has beta-amyloid plaques and tau tangles in their brain. But despite advances across blood tests, cerebrospinal fluid tests, and brain…
Many people with Alzheimer’s disease first lose neurons in their medial temporal lobe — a region of the brain involved in memory, navigation, emotional…
Years before any symptoms of Alzheimer’s appear, beta-amyloid and tau proteins misfold, tangle, and aggregate inside the brain. While many people may develop beta-amyloid…
Maybe you’ve heard of amyloid plaques, which build up in the brains of people with Alzheimer’s. But there’s another protein biomarker in the mix:…
Scientists in America have developed a nasal spray that can remove proteins in the brain associated with Alzheimer’s disease – at least, in mice….
Today, the Food and Drug Administration’s (FDA) eleven-person advisory committee unanimously voted, (11-0) that Eli Lilly’s anti-amyloid Alzheimer’s drug donanemab was effective, and that…
Lapses in memory are a fairly normal part of healthy aging. But in the early stages of neurodegenerative diseases like Alzheimer’s dementia, cognitive changes…
Although it has long been known that women are more susceptible to Alzheimer’s than men – two-thirds of Americans with Alzheimer’s are women –…
TauRx is currently running a Phase 3 trial called LUCIDITY for what they hope will become the first ever Alzheimer’s pill. But they’ve had…
Like an aged book, DNA in the brain acquires wear and tear during your lifespan. Earlier this year, researchers from Brigham and Women’s Hospital…
A new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia (PPA) have Alzheimer’s-like plaques and tangles in their brains…
The busy life of brain cells is not so different from the supply chain that supports online purchases. A transaction is registered at a…
The Alzheimer’s research community has been working for decades to find an effective treatment for Alzheimer’s disease, largely by targeting one of the hallmarks…
While some scientists are focused on targeting beta-amyloid plaques to treat Alzheimer’s, others are honing in on another hallmark of the disease — pathological…
The toxic accumulation of four abnormal proteins in the brain is such a harbinger of cognitive decline, one researcher has taken to calling them…